N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway
Yu Yin(First Affiliated Hospital of Anhui Medical University), Jiaoti Huang(Duke University)
Cited by 120
Related Papers
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
|Science Translational Medicine|2019|136
All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy
|BMC Complementary and Alternative Medicine|2016|60
N‑Myc induces the tumor progression of prostate cancer by regulating FSCN1
|Oncology Reports|2020|15
CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3
|International Journal of Oncology|2024|14